The Enterprise Value as of September 2024 (TTM) for 9 Meters Biopharma, Inc. (NMTR) is -725468.00

According to 9 Meters Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -725468.00. This represents a change of -102.12% compared to the average of 34.28M of the last 4 quarters.

9 Meters Biopharma, Inc. (NMTR) Historical Enterprise Value (quarterly & annually)

How has NMTR Enterprise Value performed in the past?

The mean historical Enterprise Value of 9 Meters Biopharma, Inc. over the last ten years is 49.15M. The current -725468.00 Enterprise Value has changed -247.59% with respect to the historical average. Over the past ten years (40 quarters), NMTR's Enterprise Value was at its highest in in the June 2018 quarter at 599.12M. The Enterprise Value was at its lowest in in the December 2021 quarter at -46825347.00.

9 Meters Biopharma, Inc. (NMTR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of 9 Meters Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

9 Meters Biopharma, Inc. (NMTR) Average Enterprise Value

How has NMTR Enterprise Value performed in the past?

The current Enterprise Value of 9 Meters Biopharma, Inc. (NMTR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

9 Meters Biopharma, Inc. (NMTR) Enterprise Value vs. Peers

How is NMTR’s Enterprise Value compared to its peers?

9 Meters Biopharma, Inc.’s Enterprise Value is less than Mereo BioPharma Group plc (582.99M), less than Acumen Pharmaceuticals, Inc. (93.64M), less than Day One Biopharmaceuticals, Inc. (1.01B), less than Inozyme Pharma, Inc. (343.89M), greater than Galera Therapeutics, Inc. (-5475585.00), less than Aileron Therapeutics, Inc. (38.72M), less than Artelo Biosciences, Inc. (1.27M), greater than Histogen Inc. (-3633213.00), less than Curis, Inc. (61.70M), greater than Timber Pharmaceuticals, Inc. (-798315.00), less than Kineta, Inc. (7.82M), less than Candel Therapeutics, Inc. (194.11M), less than MiNK Therapeutics, Inc. (26.26M), less than Forte Biosciences, Inc. (1.54M), greater than AlloVir, Inc. (-7576067.00), less than ZIVO Bioscience, Inc. (37.60M), less than RenovoRx, Inc. (12.72M), less than Tempest Therapeutics, Inc. (20.39M), less than Ikena Oncology, Inc. (46.38M), less than Catalyst Biosciences, Inc. (19.42M), less than MEI Pharma, Inc. (29.95M), greater than Magenta Therapeutics, Inc. (-114170976.00), less than Kezar Life Sciences, Inc. (30.16M), less than Vincerx Pharma, Inc. (15.98M), greater than Avenue Therapeutics, Inc. (-868251.00),

Build a custom stock screener for 9 Meters Biopharma, Inc. (NMTR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 9 Meters Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

9 Meters Biopharma, Inc. (NMTR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like 9 Meters Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.